40
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Case of Stevens-Johnson Syndrome Probably Induced by Herbal Medicine

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear Editor: Stevens-Johnson syndrome (SJS) is a life-threatening skin reaction characterized by extensive epidermal detachment1. Drugs, especially sulfa drugs, anti-epileptics, and antibiotics, are the most common causes1, but recently, SJS associated with herbal medication has been reported2. Herein, we report a case of SJS probably induced by herbal medicine. We received the patient's consent form about publishing all photographic materials. The study protocol was approved by the Institutional Review Board of Incheon St. Mary's Hospital, The Catholic University of Korea (IRB no. OC17ZESI0049). A 77-year-old man presented with a sudden onset of bullous lesions on his trunk and extremities (Fig. 1). The histopathological findings were sub-epidermal split with extensive epidermal necrosis (Fig. 2). The direct immunofluorescence findings were negative. Days after the skin biopsy, the vesicles and bullae began to fuse, rapidly progressing into skin erosion and denudation. The mucous membranes of the mouth and conjunctiva were also affected. Epidermal detachment was seen in less than 10% of the body surface area and the Nikolsky sign was present. The patient answered that there has been no change in his routine medication for the past 3 years, but mentioned that he started on herbal medication a month ago. The herbal medication was said to contain deer antlers, ginseng, camphor etc. Based on severity-of-illness score for toxic epidermal necrolysis, our patient's expected mortality rate was 12.1%. He was asked to immediately stop the herbal medication. The patient made a full recovery after a course of intravenous steroid therapy, daily dressings and supportive care. According to prior reports, the patch test results varied among SJS patients with culprit drug. Lin et al.3 reported that while 62.5% of patients with carbamazepine-induced SJS/toxic epidermal necrolysis (TEN) show positive patch test results, patch tests for allopurinol-induced SJS/TEN are mostly negative. As for our case, we were not able to perform a patch test on herbal medicine because the patient refused. Differential diagnoses of SJS include exfoliative dermatitis, staphylococcal scalded skin syndrome (4S), bullous pemphigoid (BP), paraneoplastic pemphigus and bullous erythema multiforme (EM). Although exfoliative dermatitis resembles SJS clinically, it rarely affects the mucosa. There is an intra-epidermal separation in 4S unlike SJS, which shows a sub-epidermal split. BP usually shows a gradual onset and spares the mucosal area. Paraneoplastic pemphigus is usually associated with an underlying cancer. As for our patient, the cancer screening tests were negative. Bullous EM is commonly triggered by herpes simplex virus infection and presents with characteristic targetoid lesions. More than 100 drugs have been reported as potential cause of SJS4, but herbal medicine induced SJS has not yet been reported in the Korean literature. Recently, several studies have reported the relationship between the human leukocyte antigen (HLA) genotype and drug hypersensitivity. Although the HLA genotype of the herbal induced SJS remained uncertain. Herbal medications carry a mixture of ingredients that originate from plants and animals. Because of this characteristic, identifying the culprit ingredient within the herbal medication is extremely difficult. Also, since there is no obligation to notify the ingredient within the medication packet, scientific evaluation in case of adverse events are nearly impossible. Herbal medication induced drug eruption can be caused by herbal medicine itself, but also by added impurities and the combination of ingredients5. With the lack of patch testing and being unable to identify the full ingredient of the herbal medicine, the authors were not able to confirm that our SJS is caused by herbal medicine. However with the clinical circumstances, we believe that herbal medicine is most likely the culprit drug in our case. We report this case because we think it is important that dermatologists consider the possibility of herbal medicine- induced drug eruption and notify the public about the potential serious side effects of herbal medicine.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.

          The aims of this review are to summarize the definitions, causes, and clinical course as well as the current understanding of the genetic background, mechanism of disease, and therapy of toxic epidermal necrolysis and Stevens-Johnson syndrome. PubMed was searched using the terms toxic epidermal necrolysis, Stevens-Johnson syndrome, drug toxicity, drug interaction, and skin diseases. Toxic epidermal necrolysis and Stevens-Johnson syndrome are acute inflammatory skin reactions. The onset is usually triggered by infections of the upper respiratory tract or by preceding medication, among which nonsteroidal anti-inflammatory agents, antibiotics, and anticonvulsants are the most common triggers. Initially the diseases present with unspecific symptoms, followed by more or less extensive blistering and shedding of the skin. Complete death of the epidermis leads to sloughing similar to that seen in large burns. Toxic epidermal necrolysis is the most severe form of drug-induced skin reaction and includes denudation of >30% of total body surface area. Stevens-Johnson syndrome affects <10%, whereas involvement of 10%-30% of body surface area is called Stevens-Johnson syndrome/toxic epidermal necrolysis overlap. Besides the skin, mucous membranes such as oral, genital, anal, nasal, and conjunctival mucosa are frequently involved in toxic epidermal necrolysis and Stevens-Johnson syndrome. Toxic epidermal necrolysis is associated with a significant mortality of 30%-50% and long-term sequelae. Treatment includes early admission to a burn unit, where treatment with precise fluid, electrolyte, protein, and energy supplementation, moderate mechanical ventilation, and expert wound care can be provided. Specific treatment with immunosuppressive drugs or immunoglobulins did not show an improved outcome in most studies and remains controversial. The mechanism of disease is not completely understood, but immunologic mechanisms, cytotoxic reactions, and delayed hypersensitivity seem to be involved. Profound knowledge of exfoliative skin diseases is needed to improve therapy and outcome of these life-threatening illnesses.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions.

            The usefulness of the drug patch testing for Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) is still controversial. Recent studies have shown that HLA-B*1502 is strongly associated with CBZ-SJS/TEN in Chinese and Southeast Asian populations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Stevens-Johnson Syndrome Induced by Vandetanib

              Vandetanib is a once-daily oral anticancer drug that selectively inhibits key signaling pathways in cancer by targeting vascular endothelial growth factor receptors, epidermal growth factor receptors tyrosine kinase, and rearranged during transfection-dependent tumor cell proliferation and survival. The most frequently reported adverse events attributed to vandetanib include diarrhea, elevated aminotransferase, asymptomatic corrected QT interval prolongation, and hypertension. Though a number of randomized, doubleblind studies, including cutaneous adverse events attributed to vandetanib, have been reported along with these general symptoms, no case of Stevens-Johnson syndrome (SJS) has been reported. This paper demonstrates a case of SJS induced by vandetanib.
                Bookmark

                Author and article information

                Journal
                Ann Dermatol
                Ann Dermatol
                AD
                Annals of Dermatology
                The Korean Dermatological Association; The Korean Society for Investigative Dermatology
                1013-9087
                2005-3894
                August 2018
                27 June 2018
                : 30
                : 4
                : 481-483
                Affiliations
                Department of Dermatology, The Catholic University of Korea, Incheon St. Mary's Hospital, Seoul, Korea.
                Author notes
                Corresponding author: Hei Sung Kim, Department of Dermatology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Korea. Tel: 82-32-280-5700, hazelkimhoho@ 123456gmail.com
                Author information
                https://orcid.org/0000-0003-0576-0474
                Article
                10.5021/ad.2018.30.4.481
                6029949
                30065594
                987e4c45-eead-46ba-8d6d-1722ecf7ca3f
                Copyright © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 11 April 2017
                : 11 August 2017
                : 14 August 2017
                Categories
                Brief Report

                Dermatology
                Dermatology

                Comments

                Comment on this article